Adjunctive Intra-Aortic Balloon Pump During Venovenous Extracorporeal Membrane Oxygenation for Severe Respiratory Failure With Cardiac Dysfunction: A Retrospective Cohort Study

Background Evidence regarding intra-aortic balloon pump (IABP) use during venovenous extracorporeal membrane oxygenation (VV-ECMO) is limited. We examined clinical outcomes and hemodynamic trajectories in patients with severe respiratory failure and cardiac dysfunction treated with or without adjunctive IABP. Methods In this single-center retrospective cohort study, five patients who received VV-ECMO + IABP were compared with 24 patients who received VV-ECMO only (16 original controls and eight additional controls with high-dose vasopressor exposure). The primary outcome was ventilator-free days through day 28 (VFD-28). Secondary outcomes included 7-day norepinephrine-equivalent and vasoactive-inotropic score (VIS) area under the curve (AUC), 72-hour lactate AUC, renal replacement therapy (RRT), mortality, and bleeding. The main sensitivity analysis compared the five VV-ECMO + IABP patients with all eight additional controls who had a norepinephrine-equivalent dose of at least 0.5 µg/kg/min on one or more days from D0 through D7. Additional sensitivity analyses used the 16 original controls and the four additional controls who met the high-dose threshold at D0. Results The VV-ECMO + IABP group had higher baseline SOFA scores, PEEP, and D0 norepinephrine-equivalent doses than the VV-ECMO-only group. Median VFD-28 was 0.0 days (interquartile range [IQR], 0.0–6.9) versus 0.7 days (IQR, 0.0–9.9; P = 0.740; rank-biserial correlation, − 0.10; 95% CI, − 0.54 to 0.41). Norepinephrine-equivalent AUC was 0.89 versus 0.76 (µg/kg/min)·day ( P = 0.600), VIS AUC was 89.2 versus 68.8 score·days ( P = 0.780), and verified 28-day mortality was 40.0% versus 37.5% ( P = 1.000). RRT duration was 5.0 versus 1.0 days ( P = 0.041), and recorded bleeding occurred in 80.0% versus 37.5% of patients ( P = 0.144). In the 5-vs-8 sensitivity analysis, VFD-28 was 0.0 versus 0.0 days ( P = 1.000), norepinephrine-equivalent AUC was 0.89 versus 2.01 (µg/kg/min)·day ( P = 0.268), and verified 28-day mortality was 40.0% versus 37.5% ( P = 1.000). Conclusions In this small retrospective cohort, adjunctive IABP during VV-ECMO was not associated with higher VFD-28, lower cumulative vasoactive exposure, or lower 28-day mortality. These findings require confirmation in studies with prospective cardiac phenotyping and larger samples.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11635255/v1
Primary Topic
Mechanical Circulatory Support Devices
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Adjunctive Intra-Aortic Balloon Pump During Venovenous Extracorporeal Membrane Oxygenation for Severe Respiratory Failure With Cardiac Dysfunction: A Retrospective Cohort Study

Zhenhua Zeng, Hanquan Shao, Hongbin Hu, Yu Gan et al.
Research Square
Mechanical Circulatory Support Devices
preprint

Adjunctive Intra-Aortic Balloon Pump During Venovenous Extracorporeal Membrane Oxygenation for Severe Respiratory Failure With Cardiac Dysfunction: A Retrospective Cohort Study

Zhenhua Zeng, Hanquan Shao, Hongbin Hu, Yu Gan, Lihan Shen, Jing Wei
preprint en

Abstract

Background Evidence regarding intra-aortic balloon pump (IABP) use during venovenous extracorporeal membrane oxygenation (VV-ECMO) is limited. We examined clinical outcomes and hemodynamic trajectories in patients with severe respiratory failure and cardiac dysfunction treated with or without adjunctive IABP. Methods In this single-center retrospective cohort study, five patients who received VV-ECMO + IABP were compared with 24 patients who received VV-ECMO only (16 original controls and eight additional controls with high-dose vasopressor exposure). The primary outcome was ventilator-free days through day 28 (VFD-28). Secondary outcomes included 7-day norepinephrine-equivalent and vasoactive-inotropic score (VIS) area under the curve (AUC), 72-hour lactate AUC, renal replacement therapy (RRT), mortality, and bleeding. The main sensitivity analysis compared the five VV-ECMO + IABP patients with all eight additional controls who had a norepinephrine-equivalent dose of at least 0.5 µg/kg/min on one or more days from D0 through D7. Additional sensitivity analyses used the 16 original controls and the four additional controls who met the high-dose threshold at D0. Results The VV-ECMO + IABP group had higher baseline SOFA scores, PEEP, and D0 norepinephrine-equivalent doses than the VV-ECMO-only group. Median VFD-28 was 0.0 days (interquartile range [IQR], 0.0–6.9) versus 0.7 days (IQR, 0.0–9.9; P = 0.740; rank-biserial correlation, − 0.10; 95% CI, − 0.54 to 0.41). Norepinephrine-equivalent AUC was 0.89 versus 0.76 (µg/kg/min)·day ( P = 0.600), VIS AUC was 89.2 versus 68.8 score·days ( P = 0.780), and verified 28-day mortality was 40.0% versus 37.5% ( P = 1.000). RRT duration was 5.0 versus 1.0 days ( P = 0.041), and recorded bleeding occurred in 80.0% versus 37.5% of patients ( P = 0.144). In the 5-vs-8 sensitivity analysis, VFD-28 was 0.0 versus 0.0 days ( P = 1.000), norepinephrine-equivalent AUC was 0.89 versus 2.01 (µg/kg/min)·day ( P = 0.268), and verified 28-day mortality was 40.0% versus 37.5% ( P = 1.000). Conclusions In this small retrospective cohort, adjunctive IABP during VV-ECMO was not associated with higher VFD-28, lower cumulative vasoactive exposure, or lower 28-day mortality. These findings require confirmation in studies with prospective cardiac phenotyping and larger samples.

Research Square
Southern Medical University (CN)
Mechanical Circulatory Support Devices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon